Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Policy Change for Deep Vein Thrombosis: Effects on Length of Stay and Hospitalization Costs of Moving From Warfarin to Direct Oral Anticoagulants.

Porath AD, Clodfelter S, Slaton T, Bookhart BK, Kozma CM, Rand ML, Bloch MJ.

Clin Ther. 2019 Feb;41(2):269-279. doi: 10.1016/j.clinthera.2018.12.006. Epub 2019 Jan 11.

PMID:
30642614
2.

A retrospective analysis to identify predictors of COPD-related rehospitalization.

Roberts MH, Clerisme-Beaty E, Kozma CM, Paris A, Slaton T, Mapel DW.

BMC Pulm Med. 2016 Apr 30;16(1):68. doi: 10.1186/s12890-016-0231-3.

3.

Healthcare costs for Crohn's disease patients treated with infliximab: a propensity weighted comparison of the effects of treatment adherence.

Feagan BG, Kozma CM, Slaton TL, Olson WH, Wan GJ.

J Med Econ. 2014 Dec;17(12):872-80. doi: 10.3111/13696998.2014.950669. Epub 2014 Aug 27.

PMID:
25162777
4.

Adherence patterns for abiraterone acetate and concomitant prednisone use in patients with prostate cancer.

Lafeuille MH, Grittner AM, Lefebvre P, Ellis L, McKenzie RS, Slaton T, Kozma C.

J Manag Care Spec Pharm. 2014 May;20(5):477-84.

5.

Complexity of pain management among patients with nociceptive or neuropathic neck, back, or osteoarthritis diagnoses.

Kozma CM, Provenzano DA, Slaton TL, Patel AA, Benson CJ.

J Manag Care Spec Pharm. 2014 May;20(5):455-66b.

6.

Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy.

Wan GJ, Kozma CM, Slaton TL, Olson WH, Feagan BG.

J Med Econ. 2014 Jun;17(6):384-93. doi: 10.3111/13696998.2014.909436. Epub 2014 Apr 16.

PMID:
24673303
7.

Cost and utilization of healthcare services for hip and knee replacement.

Kozma CM, Slaton T, Paris A, Edgell ET.

J Med Econ. 2013 Jul;16(7):888-96. doi: 10.3111/13696998.2013.802695. Epub 2013 May 23.

PMID:
23647482
8.

Opioids before and after initiation of pregabalin in patients with diabetic peripheral neuropathy.

Kozma CM, Benson C, Slaton TL, Kim MS, Vorsanger GJ.

Curr Med Res Opin. 2012 Sep;28(9):1485-96. Epub 2012 Aug 2.

PMID:
22856535
9.

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study.

Kozma CM, Paris AL, Plauschinat CA, Slaton T, Mackowiak JI.

BMC Pulm Med. 2011 Dec 22;11:61. doi: 10.1186/1471-2466-11-61.

10.

Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone palmitate: results from a clinical trial with a 52-week open-label extension (OLE).

Kozma CM, Slaton T, Dirani R, Fastenau J, Gopal S, Hough D.

Curr Med Res Opin. 2011 Aug;27(8):1603-11. doi: 10.1185/03007995.2011.595000. Epub 2011 Jun 22.

PMID:
21696265
11.

Comparative hospital economics and patient presentation: vertebroplasty and kyphoplasty for the treatment of vertebral compression fracture.

Mehio AK, Lerner JH, Engelhart LM, Kozma CM, Slaton TL, Edwards NC, Lawler GJ.

AJNR Am J Neuroradiol. 2011 Aug;32(7):1290-4. doi: 10.3174/ajnr.A2502. Epub 2011 May 5.

12.

Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.

Hodder R, Reese PR, Slaton T.

Int J Chron Obstruct Pulmon Dis. 2009;4:225-32. Epub 2009 Jun 11.

13.

Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.

Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron RL.

Eur Urol. 2007 Sep;52(3):850-8. Epub 2007 Apr 19.

PMID:
17467889
14.

Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence.

Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron R.

Arch Phys Med Rehabil. 2007 May;88(5):646-52.

PMID:
17466735
15.

Characterization and prediction of emergency department use in chronic daily headache patients.

Freitag FG, Kozma CM, Slaton T, Osterhaus JT, Barron R.

Headache. 2005 Jul-Aug;45(7):891-8.

PMID:
15985106
16.

Development and validation of a patient satisfaction and preference questionnaire for inhalation devices.

Kozma CM, Slaton TL, Monz BU, Hodder R, Reese PR.

Treat Respir Med. 2005;4(1):41-52.

PMID:
15725049
17.

A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma.

Kozma CM, Barghout V, Slaton T, Frech F, Reeder CE.

Manag Care Interface. 2002 Sep;15(9):40-3, 49.

PMID:
12244649
18.

Extremely low vertical-emittance beam in the accelerator test facility at KEK.

Kubo K, Akemoto M, Anderson S, Aoki T, Araki S, Bane KL, Blum P, Corlett J, Dobashi K, Emma P, Frisch J, Fukuda M, Guo Z, Hasegawa K, Hayano H, Higo T, Higurashi A, Honda Y, Iimura T, Imai T, Jobe K, Kamada S, Karataev P, Kashiwagi S, Kim E, Kobuki T, Kotseroglou T, Kurihara Y, Kuriki M, Kuroda R, Kuroda S, Lee T, Luo X, McCormick DJ, McKee B, Mimashi T, Minty M, Muto T, Naito T, Naumenko G, Nelson J, Nguyen MN, Oide K, Okugi T, Omori T, Oshima T, Pei G, Potylitsyn A, Qin Q, Raubenheimer T, Ross M, Sakai H, Sakai I, Schmidt F, Slaton T, Smith H, Smith S, Smith T, Suzuki T, Takano M, Takeda S, Terunuma N, Toge N, Turner J, Urakawa J, Vogel V, Woodley M, Yocky J, Young A, Zimmermann F; ATF Collaboration.

Phys Rev Lett. 2002 May 13;88(19):194801. Epub 2002 Apr 30.

PMID:
12005637
19.

High-gradient millimeter-wave accelerator on a planar dielectric substrate.

Hill ME, Adolphsen C, Baumgartner W, Callin RS, Lin XE, Seidel M, Slaton T, Whittum DH.

Phys Rev Lett. 2001 Aug 27;87(9):094801. Epub 2001 Aug 10.

PMID:
11531569
20.
21.

A performance study of the Loma Linda proton medical accelerator.

Coutrakon G, Hubbard J, Johanning J, Maudsley G, Slaton T, Morton P.

Med Phys. 1994 Nov;21(11):1691-701.

PMID:
7891629

Supplemental Content

Loading ...
Support Center